Product Notes

car t cell design: Chimeric antigen receptor (CAR)-engineered γδ T cell represents a new type of immunotherapy that utilizes T cell immunity against various kinds of tumors. There is increasing evidence to report the exciting results of CAR-modified γδ T cells in the treatment of cancer. γδ T cells, an important population of T cells, have several advantages in fighting tumor cells such as strong cytotoxic effects on tumor cells. They are considered as promising candidates for developing cell immunotherapy.
Learn more: https://gammadelta-t-therapy.creative-biolabs.com/car-engineered-t-cell-development-services.htm